Natco Pharma Executive VP - Technology Transfer, Intellectual Property Rights & Regulatory Affairs (API), Dr Ramesh Dandala, superannuates Ruchika Sharma4 April 2025 1:30 PM ISTTelangana: Natco Pharma has announced the superannuation of Dr Ramesh Dandala, Executive Vice President - Technology Transfer, Intellectual...
Natco Pharma Tummala Venkata Rao supperannuates as Vice President - Production Ruchika Sharma1 April 2025 5:22 PM ISTNatco Pharma has announced the supperannuation of Tummala Venkata Rao, Vice President - Production of the Company."With effect from the closure...
Setback to Roche: Plea Against Natco on Risdiplam Patent Rejected by Delhi HC Farhat Nasim25 March 2025 5:31 PM ISTNew Delhi: In a major relief to Indian drugmaker Natco Pharma, the Delhi High Court has rejected an interim injunction plea filed by Swiss...
Natco Pharma appoints Bhimrao Dattu Jadhav as Senior Vice President -Operations (Formulations) for Pharma Division - Kothu Ruchika Sharma4 March 2025 11:30 AM ISTTelangana: Natco Pharma has appointed Bhimrao Dattu Jadhav as Senior Vice President - Operations (Formulations) for Pharma Division - Kothur of the...
Natco Pharma appoints G Vasan as Vice President - (Operations) Ruchika Sharma28 Feb 2025 10:30 AM ISTNatco Pharma has announced that G. Vasan has been designated as Vice President - (Operations) of the Company w.e.f. 27th February, 2025.G. Vasan is a...
Natco Pharma Q3 Profit Falls 38% to Rs132 Cr Amid Formulation Export Slump Farhat Nasim14 Feb 2025 1:30 PM ISTNatco reported consolidated revenue of Rs 474.8 crore for the quarter, down from Rs 758.6 crore a year ago.
Dr Pavan Ganapati Bhat resigns as Director & Executive Vice President (Technical Operations) of Natco Pharma Ruchika Sharma13 Feb 2025 12:30 PM ISTTelangana: Natco Pharma has announced the resignation of Dr Pavan Ganapati Bhat as Director & Executive Vice President (Technical Operations) of...
Natco Pharma gets final approval for Bosentan tablets for oral suspension Ruchika Sharma10 Feb 2025 11:30 AM ISTHyderabad: NATCO Pharma Limited has announced final approval of its Abbreviated New Drug Application (ANDA) for Bosentan tablets for oral...
Natco Pharma gets approval for Everolimus tablets for Oral Suspension for subependymal giant cell astrocytoma Ruchika Sharma30 Jan 2025 11:30 AM ISTHyderabad: NATCO Pharma Limited, an Indian pharmaceutical company, has announced the approval of its Abbreviated New Drug Administration...
Natco Pharma sells land in Telangana for Rs 116 crore Ruchika Sharma28 Nov 2024 3:30 PM ISTTelangana: Natco Pharma has sold clear and marketable titles of land admeasuring approximately 14.38 Acres i.e., 72,358 Sq. yards (hereinafter...
Natco Pharma submits application with USFDA for Risdiplam for Oral Solution Ruchika Sharma26 Nov 2024 3:21 PM ISTHyderabad: Natco Pharma, an Indian pharmaceutical company has announced the submission of an Abbreviated New Drug Application (ANDA)...
Natco Pharma appoints Madhava Rao Karicherla as Associate Vice President - Formulation RnD, Pharma Division, Kothur Unit Ruchika Sharma16 Nov 2024 11:00 AM ISTTelangana: Natco Pharma has announced that Madhava Rao Karicherla has been appointed as Associate Vice President - Formulation Research &...
